F.D.A. to Expand Medication-Assisted Therapy for Opioid Addicts

The agency will embrace treatment that “does not require the patient to be totally clean at every visit,” as long as the patient shows continuing improvement.

Considering the Side Effects of Drugmakers’ Money-Back Guarantees

The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.